DeerRun Brings Social Fitness to IFA 2026: Move. Compete. Connect.
BERLIN, Sept. 7, 2026 /PRNewswire/ — Home fitness has traditionally been a solitary experience. At IFA Berlin 2026 this week, DeerRun…
Culture
Another Versatile Android Tablet Alternative: Huion Kamvas Pad 12 Unveiled
LOS ANGELES, Sept. 7, 2026 /PRNewswire/ — Today, Huion officially announced its new Android tablet, the Kamvas Pad 12, one year…
Redefining the Safety Ceiling for Small EVs! AION UT Earns 2026 Euro NCAP Five-Star Rating
BRUSSELS, Sept. 7, 2026 /PRNewswire/ — In the automotive world, Euro NCAP (European New Car Assessment Programme) is widely recognized as…
Global Flavors Unite in Guangzhou: SIAL West Asia Exhibition Opens, Connecting the World’s F&B Pulse
GUANGZHOU, China, Sept. 5, 2026 /PRNewswire/ — A report from Iqingdao.On September 3, the 2026 SIAL West Asia International Food…
Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women
The association’s Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women…
Global pharmacy leaders identify priorities for integrating pharmacists into primary health care
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ — Pharmacy leaders, invited from around the world, gathered in Montréal today for an international…
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate…
Back-to-School Health: Helping Children Start the School Year Strong with Accordia Health
SARALAND, Ala., Aug. 26, 2026 /PRNewswire/ — As students return to school, parents are busy with supply lists, shopping for…
Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
– ASP2138’s advancement into Phase 3 marks an important milestone in Astellas’ commitment to advancing research in CLDN18.2 with its…
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 23, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company, today…
NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
WASHINGTON, Aug. 22, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the NEREUS™ branded No. 47 entry…
AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma
ROCKVILLE, Md. and SHANGHAI, Aug. 16, 2026 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical…